1 |
Ahima R, Flier J (2000). Adipose tissue as an endocrine organ. Trends Endocrinol Metabolism, 11, 327-32.
DOI
|
2 |
Ahima R (2006). Adipose tissue as an endocrine organ. Obesity, 14, 242-9.
DOI
|
3 |
Akinci M, Kosova F, Cetin B, et al (2009). Leptin levels in thyroid cancer. Asian J Surg, 32, 216-23.
DOI
|
4 |
Liang J, Zubovitz J, Petrocelli T, et al (2002). PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nature Med, 8, 1153-60.
DOI
|
5 |
Mandal P, Pratt B, Barnes M, et al (2011). Molecular mechanism for Adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J Biological Chem, 286, 13460-9.
DOI
|
6 |
Mitsiades N, Pazaitou-Panayiotou K, Aronis K, et al (2011). Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies. J Clin Endocrinol Metabolism, 96, 2023-8.
DOI
|
7 |
Otvos L, Haspinger E, La Russa F, et al (2011). Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol, 11, 90.
DOI
|
8 |
Paz-Filho G (2011). Associations between adipokines and obesity-related cancer. Frontiers Bioscience, 16, 1634.
DOI
|
9 |
Park J, Euhus D, Scherer P (2011). Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression. Endocrine Rev, 32, 550-70.
DOI
|
10 |
Peso L (1997). Interleukin-3-induced phosphorylation of BAD through the Protein Kinase Akt. Science, 278, 687-9.
DOI
|
11 |
Berg A, Combs T, Scherer P (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinol Metabolism, 13, 84-9.
DOI
|
12 |
Banks A (2000). Activation of downstream signals by the long form of the leptin receptor. J Biological Chemistry, 275, 14563-72.
DOI
|
13 |
Barb D, Williams C, Neuwirth A, Mantzoros C (2007). Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr, 86, 858-66.
DOI
|
14 |
Baratta M (2002). Leptin-from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit, 8, 282-92.
|
15 |
Booth A, Magnuson A, Fouts J, Foster M (2015). Adipose tissue, obesity and adipokines: role in cancer promotion. Hormone Molecular Biol Clin Investigat.
|
16 |
Danese E, Minicozzi AM, Montagnana M, et al (2013). Lack of an Association between circulating adiponectin levels and risk of colorectal adenoma. Clinical Laboratory.
|
17 |
Pezzilli R, Barassi A, Corsi M, et al (2010) Serum leptin, but not adiponectin and receptor for advanced glycation end products, is able to distinguish autoimmune pancreatitis from both chronic pancreatitis and pancreatic neoplasms. Scandinavian J Gastroenterol, 45, 93-9.
DOI
|
18 |
Pontikides N, Krassas G (2007). Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid, 17, 421-31.
DOI
|
19 |
Segev D, Umbricht C, Zeiger M (2003). Molecular pathogenesis of thyroid cancer. Surgical Oncol, 12, 69-90.
DOI
|
20 |
Cheng S, Chi C, Tzen C, et al (2010). Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery, 147, 847-53.
DOI
|
21 |
Di Cristofano A (2013). Obesity and thyroid cancer: Is Leptin the (Only) Link? Endocrinol, 154, 2567-9.
DOI
|
22 |
Fruhbeck G (2006). Intracellular signalling pathways activated by leptin. Biochem J, 393, 7-20.
DOI
|
23 |
Griebeler M, Gharib H, Thompson G (2013). Medullary thyroid carcinoma. Endocrine Practice, 19, 703-11.
DOI
|
24 |
Hedayati M, Yeganeh M, Sheikholeslami S, Azizi F (2015). Wide screening of RET proto-oncogene in Iranian medullary thyroid carcinoma patients: 13 years study. Endocrine Abstracts.
|
25 |
Stevens V, Jacobs E, Sun J, Gapstur S (2014). No association of plasma levels of adiponectin and c-peptide with risk of aggressive prostate cancer in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev, 23, 890-2.
DOI
|
26 |
Tworoger S, Eliassen A, Kelesidis T, et al (2007). Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metabolism, 92, 1510-6.
DOI
|
27 |
Uddin S, Bu R, Ahmed M, et al (2010). Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma. Leukemia Lymphoma, 51, 1305-14
DOI
|
28 |
Hedayati M, Zarif Yeganeh M, Sheikhol Eslami S, et al (2011). Predominant RET germline mutations in exons 10, 11, and 16 in iranian patients with hereditary medullary thyroid carcinoma. J Thyroid Res, 2011, 1-6.
|
29 |
Hedayati M, Nabipour I, Rezaei-Ghaleh N, Azizi F (2006). Germline RET mutations in exons 10 and 11: an Iranian survey of 57 medullary thyroid carcinoma cases. Med J Malaysia, 61, 564-9.
|
30 |
Hedayati M, Yaghmaei P, Pooyamanesh Z, et al (2011). Leptin: A Correlated Peptide to Papillary Thyroid Carcinoma? J Thyroid Res, 2011, 1-5.
|
31 |
Bub J, Miyazaki T, Iwamoto Y (2006). Adiponectin as a growth inhibitor in prostate cancer. Biophys Res Commun, 340, 1158-66.
DOI
|
32 |
Howard J, Pidgeon G, Reynolds J (2010). Leptin and gastrointestinal malignancies. Obesity Rev, 11, 863-74.
DOI
|
33 |
Kim A, Lee Y, Kim K, et al(2010). Adiponectin Represses Colon Cancer Cell Proliferation via AdipoR1- and -R2-Mediated AMPK Activation. Molecular Endocrinol, 24, 1441-52.
DOI
|
34 |
Kadowaki T, Yamauchi T (2005). Adiponectin and Adiponectin Receptors. Endocrine Rev, 26, 439-51.
DOI
|
35 |
Kaklamani V, Wisinski K, Sadim M, et al (2008). Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA, 300, 1523-31
DOI
|